Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2018
DOI: 10.15171/jcvtr.2018.28
|View full text |Cite
|
Sign up to set email alerts
|

ECMO-assisted resection of huge thoracic mass

Abstract: Some advanced thoracic malignancy cannot be resected safely by using of conventional ventilation, so some sort of cardiopulmonary support is needed for hemodynamic and ventilation management of the patient. Using extracorporeal membrane oxygenation (ECMO) in comparing with cardiopulmonary bypass has some advantages. Three patients with huge thoracic tumors with different ages experienced major surgery in our center by using ECMO in order to face major complications mainly due to the size of mass to achieve bet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 7 publications
(7 reference statements)
0
2
0
Order By: Relevance
“…ECMO has been widely used during recent years for cardiopulmonary support ( 56 ). This device has greatly helped patients with severe ARDS in viral epidemics like influenza H1N1 with a success rate of up to 60% ( 56 ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…ECMO has been widely used during recent years for cardiopulmonary support ( 56 ). This device has greatly helped patients with severe ARDS in viral epidemics like influenza H1N1 with a success rate of up to 60% ( 56 ).…”
Section: Introductionmentioning
confidence: 99%
“…ECMO has been widely used during recent years for cardiopulmonary support ( 56 ). This device has greatly helped patients with severe ARDS in viral epidemics like influenza H1N1 with a success rate of up to 60% ( 56 ). Considering lung involvement and the high incidence of ARDS in COVID-19 disease, the use of this tool has been considered in China, but the results have not been very encouraging so far ( 57 ).…”
Section: Introductionmentioning
confidence: 99%